Refine by
Cancer Detection Articles & Analysis
54 articles found
ICA is one of the most successful and widely used point-of-care tests (POCT) and has been successfully used for human chorionic gonadotropin (hCG) detection, serodiagnostic assays, cancer detection, cardiac markers and infectious microorganism detection. ...
In basic research, QDL has been used to study cell signaling, track the dynamics of specific proteins, and visualize complex cellular structures with high resolution. In cancer research, QDs have been used to target and image cancer biomarkers, enabling early detection and personalized diagnostics. ...
For example, exosomal RNA sequencing has shown promise for the early detection of cancer, including pancreatic, lung, and breast cancer. In one study, researchers were able to identify a set of exosomal miRNAs that could distinguish pancreatic cancer patients from healthy controls with high accuracy. Similarly, another study ...
Traditional approaches often fall short in detecting cancers early or accurately characterizing subtypes necessary for effective treatment. ...
Analyzing the biological components in TME helps to detect harmful substances in cells as early as possible, facilitating early detection, diagnosis, and treatment. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
CDH1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway, which is often dysregulated in cancer. What is the role of CDH1 in cancer? The loss or dysfunction of CDH1 has been implicated in the development and progression of various types of cancer. ...
How is nano-flow cytometry being used to improve early disease detection? Cancer detection: Nano-flow cytometry is being used by researchers to create new blood tests that can identify cancer cells in their earliest stages. As an illustration, scientists at the University of California, Los Angeles have created a brand-new blood ...
WES offers a simpler, more cost-effective, and efficient alternative to whole genome sequencing, with higher target region coverage, facilitating accurate variant detection. Enhancing Cancer Genomic Research with WES Mutations occurring within the whole exome regions of the cancer genome play a pivotal role in tumor development. WES's precise ...
INOVIQ (IIQ) signs a contract research agreement with Nicoya Lifesciences to develop a SubB2M-based test that uses its Alto digital surface plasmon resonance (SPR) platform The company believes a SubB2M-based SPR test has the potential to be developed as a multi-cancer detection test that first detects the Neu5Gc cancer ...
Analysis of microbiome signatures in plasma for early CRC detection Colorectal cancer (CRC) represents the 3rd leading cause of cancer-related deaths in the United States. Patients diagnosed with distant stage of the disease represent 22% of all CRC cases and have 15% 5-years survival rates, in contrast to 91% 5-years survival rate of patients ...
Company Presents Data at ESMO Congress Showing Link Between Microbiome Bacteria and Early Colorectal Cancer Detection (September 12, 2022) CAMBRIDGE, MA. - Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results of a proof of principle ...
Yale Medicine, an academic medical center with a high volume of prostate biopsies, conducted a study to determine Paige Prostate’s utility as a prescreening tool for clinical use. A total of 1,876 prostate core biopsy slides were analyzed by Paige Prostate, and only those cores categorized by the AI as “suspicious” or as out of distribution were manually reviewed by Yale ...
All three companies are excited to bring such a product into the market with one goal—improving early breast cancer detection. Day 2 Technical training for Datascan engineers continued on the mobile unit. ...
Organizations Martini-Klinik Prostate Cancer Center and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany, MDxHealth, B.V., Nijmegen, Netherlands, MDxHealth, Inc., Irvine, CA, Mathematical Modeling, Statistics and Bioinformatics, Ghent University, Ghent, Belgium, Martini-Klinik Prostate Cancer Center, University Hospital ...
The use of tumour markers to diagnose, assess prognosis, and select a suitable cancer treatment has become possible due to the development of inexpensive and user-friendly molecular analysis tools such as the polymerase chain reaction (PCR). Maintaining the integrity of biomarkers during their processing and storage is therefore of critical importance to accurately diagnose and give prognosis ...
Abnormalities in fatty acid metabolism are commonly seen in cancer. A growing number of studies have shown that increased ab initio synthesis of fatty acids in tumor cells is a prominent feature in the development of cancer. ...
Summary OTraces in collaboration with the Gertsen Institute in Moscow performed a blinded validation study on OTraces breast cancer detection products, the CDx Chemistry System for processing automated tests for detection of cancer; BC Sera Dx Immunochemistry test kit for the measurements of proteins that are predictive as a ...
In the artificial intelligence project, studies are continuing under four main titles: breast cancer, prostate cancer, lung and colorectal cancer. Breast cancer module is a trainable model for identification and scoring of Nottingham grading parameters which are mitosis, nuclear pleomorphism and tubular differentiation. The ...